Thursday, January 31, 2008

Viventia Biotech Reports Positive Data From Cancer Trial

Viventia Biotech provided an update on clinical development programs for Proxinium, Vicinium, VB6-845 for cancer treatment. Continue reading ...

In people with high blood pressure as part of metabolic syndrome, a cluster of conditions that increases the risk for heart disease, diuretics offer greater protection against cardiovascular disease. Continue reading ...

Adult obesity-related health conditions could cost Minnesota at least an additional $900 million per year by 2010 and $3.7 billion more per year by 2020. Continue reading ...

One in ten Americans report suffering regularly from various physical aches, pains and debilitating arthritis. Continue reading ...

GfK Asia released its premier retail audit data on the 2007 Optics industry in China covering the contact lens market. Continue reading ...

0 comments: